PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services Apr 9, 2021
MINDCURE Announces Additional Equity Investment in ATMA; Kelsey Ramsden Named to ATMA Board of Directors Apr 8, 2021
MINDCURE Files Provisional Patent Application For iSTRYM, its Digital Therapeutics (DTx) SaaS Platform Mar 31, 2021
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin Mar 23, 2021